Nox Medical, the sleep medical device branch of Nox Health, has revolutionized home sleep testing with the launch of its newest device, the Nox T3s. The Nox T3s is based on the world-renowned Nox T3, which launched in 2009 and quickly became, for many, the standard for home sleep testing. The Nox T3s maintains the brand’s commitment to patient comfort and clinical accuracy, with the Nox RIP technology for more sophisticated sleep time estimation.
“For more than 10 years, the Nox T3 has led the industry in-home sleep testing,” said Pétur Már Halldórsson, CEO of Nox Medical. “Like the Nox T3 before it, the Nox T3s is designed to be reliable, ergonomic and streamlined, with modern enhancements to help it fit seamlessly into an efficient workflow. The Nox T3s combines smart technology and simplicity in a single device that will change how specialists test, analyze and treat patients.”
The Nox T3s features Nox Medical’s newest innovation, the Nox BodySleep analysis*, which allows physicians to assess patients’ sleep time in a home environment without complicating or compromising the patient experience. The Nox BodySleep analysis, available within the Noxturnal software, is a new and validated method that uses an artificial intelligence (AI) algorithm to analyze respiratory and actigraphy factors for more accurate Apnea-Hypopnea Index (AHI) estimation.
“For many physicians, the inability to accurately measure sleep in patients’ homes has prevented them from adopting home sleep testing offerings into their practice,” Halldórsson said. “Now, physicians can not only administer at-home sleep tests, they can feel confident in the results and use them to determine the best course of treatment for each unique patient.”
Together, the Nox T3s and the Noxturnal software utilize cutting-edge technology that provides automatic analyses of patients’ results. In published papers, Noxturnal software has demonstrated a near-perfect correlation between its built-in algorithm for respiratory scoring and manually scored AHI.
“Our goal with the Nox T3s and our Noxturnal software is to equip sleep specialists with the tools and data to understand disordered breathing in a more complete way by looking beyond the AHI,” said Halldórsson. “We believe better data leads to better diagnoses, which leads to more effective treatment. To everyone who loves our Nox T3, we cannot wait for you to experience the Nox T3s and see firsthand how it can elevate your home sleep testing and diagnostics capabilities.”
The Nox T3s was introduced during an online product launch on June 23rd. View the launch video at noxmedical.com/launchevent. The availability of the Nox T3s may vary between markets. Please contact your local distributor or U.S. sales representative for further information by visiting our website: noxmedical.com/contact/.
*The Nox BodySleep™ analysis is not available in the United States.
Source: Nox Medical